SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-017894
Filing Date
2023-05-04
Accepted
2023-05-04 16:19:14
Documents
52
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rlay-20230331.htm   iXBRL 10-Q 2414911
2 EX-31.1 rlay-ex31_1.htm EX-31 22231
3 EX-31.2 rlay-ex31_2.htm EX-31 22164
4 EX-32.1 rlay-ex32_1.htm EX-32 20873
  Complete submission text file 0000950170-23-017894.txt   7985278

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rlay-20230331_lab.xml EX-101.LAB 414199
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rlay-20230331.xsd EX-101.SCH 51088
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rlay-20230331_def.xml EX-101.DEF 194296
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rlay-20230331_cal.xml EX-101.CAL 46561
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rlay-20230331_pre.xml EX-101.PRE 308725
46 EXTRACTED XBRL INSTANCE DOCUMENT rlay-20230331_htm.xml XML 1486705
Mailing Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139
Business Address 399 BINNEY STREET 2ND FLOOR CAMBRIDGE MA 02139 617-370-8837
Relay Therapeutics, Inc. (Filer) CIK: 0001812364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39385 | Film No.: 23889047
SIC: 2836 Biological Products, (No Diagnostic Substances)